| Budget Amount *help |
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1989: ¥300,000 (Direct Cost: ¥300,000)
Fiscal Year 1988: ¥1,600,000 (Direct Cost: ¥1,600,000)
|
|---|
| Research Abstract |
Eicosapentaenoic acid (EPA) was purified from muscle of sardine and acylated to glycerol. Trieicosapentaenoyl-glycerol (EPA-TG) syntherized this way was emulsified with egg yolk lecithin. Glycerol (2.5%) was further added to maintain osmotic pressure of the emulsion. To rabbits (3-3.5kg) was infused 30ml of the emulsion (3g EPA) through ear veins. Blood samples were obtained from ear arteries before, and 6, 24 and 168 h after the infusion. Polymorphonuclear leukocytes were prepared and stimulated calcium ionophore. The supernatant was extracted for leukotriene B_4 and B_5 (LTB4/5) and measured by high performance liquid chromatography. In the control experiments commercially available soybean oil emulsion was used instead of EPA emulsion.
Averaged LTB_4 production by leukocytes 6, 24 and 168 h after EPA infusion was 60 (p<0.05), 72 and 86% of the pre-infusion levels, respectively. LTB_5 production, which was below the detection limits before the infusion, was similar to that of LTB_4 6 h after the infusion, and then decreased afterward. In the control experiments there were no significant changes in LTB_4 production. LTB_5 production was below the detection limits throughout the control experiments.
LTB_4 (but not LTB_5) is a potent chemoattractant and aggregant of leukocytes, and intimately related with tissue damage due to acute inflammation (including acute myocardial infarction and graft rejection). Infusion of EPA can depress LTB_4 production very quickly. Consequently, EPA emulsion may be useful for the clinical situations described above.
|
